Showing results (21-30 of 781) with videos related to

Sort By:
Pageof 79
Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Leukemia|March 1, 2018
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2017
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple MyelomaXiaoyan Feng, Li Zhang, Chirag Acharya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple MyelomaMorihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Experimental Hematology|March 8, 2002
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implicationsYu-Tzu Tai, Klaus Podar, Stine-Kathrein Kraeft, et al.
British Journal of Haematology|May 20, 2003
Recombinant humanized anti-CD40 monoclonal antibody triggers autologous antibody-dependent cell-mediated cytotoxicity against multiple myeloma cellsToshiaki Hayashi, Steven P Treon, Teru Hideshima, et al.
Blood|July 16, 2016
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implicationGang An, Chirag Acharya, Xiaoyan Feng, et al.
Pageof 79